The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders-Reference-Cited by-同舟云学术

The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders

Published:2018-09 Issue:9 Volume:33 Page:1376-1389
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Damato Valentina¹²,Balint Bettina¹³⁴,Kienzler Anne-Kathrin¹,Irani Sarosh R.¹⁴

Affiliation:

1. Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences; University of Oxford; Oxford UK

2. Institute of Neurology, Department of Neuroscience; Catholic University; Rome Italy

3. Department of Neurology; University Hospital; Heidelberg Germany

4. Oxford University Hospitals; John Radcliffe Hospital; Oxford UK

Funder

Wellcome Trust

UCB-Oxford University Alliance

Margaret Temple (2017) Grants

Epilepsy Research UK

Fulbright UK-US commission (MS-society research award)

National Institute for Health Research Oxford Biomedical Research Centre

NHS

National Institute for Health Research

EAN

British Medical Association

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27446/fullpdf

Reference118 articles.

1. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms;Irani;Ann Neurol,2014

2. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions;Varley;JNeurol,2014

3. Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology;Balint;Brain,2018

4. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse;Dalmau;Neurology,2016

5. Movement disorders in autoimmune diseases;Baizabal-Carvallo;Mov Disord,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Basal Ganglia Encephalitis Associated With Anti-N-methyl-d-Aspartate Receptor Antibodies in Children;Pediatric Neurology;2024-04

2. Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors;Movement Disorders Clinical Practice;2024-02-23

3. Anti-carbamylated protein antibodies drive AEC II toward a profibrotic phenotype by interacting with carbamylated TLR5;Rheumatology;2024-02-16

4. Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review;Brain Sciences;2024-02-14

5. Movement disorders associated with pediatric encephalitis;Handbook of Clinical Neurology;2024